Company Background and Transformation Drivers - Jiangxi Yintao Pharmaceutical Co., Ltd. is a national high-tech enterprise engaged in R&D, production, and sales, covering traditional Chinese medicine, chemical raw materials, and formulations, with products spanning 9 categories, 18 series, and 158 drug approvals [1] - The company faces challenges due to new medical reforms, centralized procurement policies, intensified market competition, and stricter regulations, including a lack of unified information platforms, compliance issues, and disorganized accounts receivable [2] Solution Design and Platform Deployment - Yintao Pharmaceutical has chosen to deploy Kingdee Cloud's flagship version to create an integrated platform of "ERP + GSP Compliance Cloud," aiming for unified master data standards and seamless business chain connectivity [3] Key Construction Highlights - A centralized ERP platform has been established to manage master data and close business process loops, enhancing collaboration across subsidiaries [5] - Integration of GSP compliance processes with the ERP supply chain ensures drug quality traceability and operational efficiency [6] - A dual-dimensional credit and receivables management system has been implemented to mitigate bad debt risks [7][8] - A unified financial accounting system has been created to enable detailed cost accounting and business-financial integration [9] Impact of Digital Transformation and Management Value - The establishment of a complete digital marketing chain allows real-time order status tracking and profit visibility for sales personnel and managers [10] - Enhanced inventory visibility and customer satisfaction through real-time data across procurement, production, quality, and sales [11] - The multi-organization accounting structure supports both corporate financial accounting and internal management, driving cost reduction and profit enhancement [12] Summary - Jiangxi Yintao Pharmaceutical, in collaboration with Kingdee Cloud, is transforming its operations with a focus on "full-process business closure + GSP compliance control + financial standard enhancement," moving from fragmented systems to a unified platform and from coarse management to refined operations, thereby strengthening its resilience and preparing for high-quality growth in the capital market [13]